Clinical Trials Logo

Microsatellite Instability clinical trials

View clinical trials related to Microsatellite Instability.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06238193 Completed - Colorectal Cancer Clinical Trials

Molecular Characteristics of Early-onset Compared With Late-onset Colorectal Cancer

Start date: January 1, 2003
Phase:
Study type: Observational

The distribution rate of microsatellite instability-high (MSI-H) was significantly higher in early-onset colorectal cancer, and early-onset colorectal cancer has a specific mutational profile and relatively high programmed cell death ligand 1(PD-L1) expression, which may be used to guide personalized treatment to better control the disease.

NCT ID: NCT05535569 Completed - Clinical trials for Recurrent/Metastatic Gastric Cancer

Phase Ib/II Study to Evaluate the Safety and Efficacy of Nivolumab in Combination With Paclitaxel in Epstein-Barr Virus(EBV)-Related, or Microsatellite Instability-High (MSI-H), or Programmed Cell Death Ligand 1 (PD-L1) Positive Advanced Gastric Cancer

Start date: July 17, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

This is a Phase Ib/II study to identify the recommended dose of paclitaxel and nivolumab for further study, and to assess the safety and clinical efficacy of this combined treatment in EBV-related, MSI-high, or PD-L1 positive advanced gastric cancer after first line treatment.

NCT ID: NCT05162248 Completed - Colorectal Cancer Clinical Trials

Microsatellite Instability in Colorectal Cancers

MSI-CRC
Start date: April 1, 2021
Phase:
Study type: Observational

In this study, we aimed to identify the different histopathological features of tumors with microsatellite instability (MSI) compared to microsatellite stable (MSS) in patients who underwent surgery for colorectal cancer. We also planned to determine how MSI affects prognostic parameters.

NCT ID: NCT04482608 Completed - Clinical trials for Colorectal Cancer Metastatic

The mCRC Patients With pMMR/MSS or dMMR/MSI-H Status Received Palliative Chemotherapy Efficacy and Survival

Start date: September 1, 2019
Phase:
Study type: Observational

Deficient mismatch repair (dMMR) or microsatellite instability high (MSI-H) accounts for 4-5% in metastatic colorectal cancer (mCRC). The efficacy and survival of patients with dMMR/MSI-H status received palliative chemotherapy have not clear yet. In this study, the investigators observed the efficacy and survival of dMMR/MSI-H status mCRC patients received palliative first-line chemotherapy.

NCT ID: NCT04232020 Completed - Gastric Cancer Clinical Trials

A Retrospective Validations Microsatellite Instability (MSI) Testing v Mismatch Repair (MMR) in Gastric Adenocarcinoma

Start date: February 7, 2020
Phase:
Study type: Observational

To compare the Idylla microsatellite instability test versus mismatch repair immunohistochemistry (IHC) in gastric adenocarcinoma.

NCT ID: NCT03841110 Completed - Colorectal Cancer Clinical Trials

FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors

Start date: February 15, 2019
Phase: Phase 1
Study type: Interventional

FT500 is an off-the-shelf, iPSC-derived NK cell product that can bridge innate and adaptive immunity, and has the potential to overcome multiple mechanisms of immune checkpoint inhibitor (ICI) resistance. The preclinical data provide compelling evidence supporting the clinical investigation of FT500 as monotherapy and in combination with ICI in participants with advanced solid tumors.

NCT ID: NCT03538028 Completed - Ovarian Cancer Clinical Trials

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

Start date: June 18, 2018
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the safety, tolerability, and preliminary efficacy of INCAGN02385 in participants with advanced malignancies.

NCT ID: NCT03495674 Completed - Clinical trials for High-Frequency Microsatellite Instability

Cycling in Preventing Colorectal Cancer in Participants With Lynch Syndrome

Start date: April 4, 2018
Phase: N/A
Study type: Interventional

This trial studies how well cycling works in preventing colorectal cancer in participants with Lynch syndrome. Exercise such as cycling may reduce colorectal cancer risk in participants with Lynch syndrome.

NCT ID: NCT03485196 Completed - Gastric Cancer Clinical Trials

The Relationship Between Microsatellite Instability and Efficacy of Fluorouracil Based Adjuvant Chemotherapy in Gastric Cancer After Operation

Start date: March 1, 2017
Phase:
Study type: Observational

The relationship between Microsatellite instability and efficacy of fluorouracil based adjuvant chemotherapy in gastric cancer after operation.

NCT ID: NCT03136523 Completed - Lung Cancer Clinical Trials

Tissue Microarrays (TMAs) Construction in Lung Cancer Samples

LUNGTMA
Start date: March 2016
Phase:
Study type: Observational

Construction of a large cohort of lung cancer patients to evaluate the Prognostic and Predictive Significance of the molecular biomarkers Epidermal growth factor receptor (EGFR), KRAS, Anaplastic lymphoma kinase (EML4-ALK), Programmed Death-Ligand 1 (PD-L1) protein and Microsatellite Instability (MSI) in lung cancer: A tissue microarray-based study of 500 cases.